Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Passage BIO, Inc. Director's Dealing 2024

Oct 2, 2024

34849_dirs_2024-10-02_d6c9186d-fdc1-4a8a-b38a-7a8e1c7f8e1a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2024-09-10

Reporting Person: Kassberg Thomas Richard (N/A)

More from Passage BIO, Inc.

Regulatory Filings 2026
May 27
Regulatory Filings 2026
May 26
Interim / Quarterly Report 2026
May 12
Regulatory Filings 2026
Apr 28
Regulatory Filings 2026
Apr 20
Annual Report 2026
Apr 7
Proxy Solicitation & Information Statement 2026
Apr 7
Director's Dealing 2026
Mar 18
Annual Report 2026
Mar 3
Regulatory Filings 2026
Mar 3
View all filings →